NIH Charters Cancer Advisory Panel on Alternative Medicine

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 6
Volume 8
Issue 6

BETHESDA, Md-The National Institutes of Health (NIH) has chartered its Cancer Advisory Panel for Complementary and Alternative Medicine, limiting the group’s lifetime to 2 years unless it is formally renewed.

BETHESDA, Md—The National Institutes of Health (NIH) has chartered its Cancer Advisory Panel for Complementary and Alternative Medicine, limiting the group’s lifetime to 2 years unless it is formally renewed.

The panel was initially organized last November to advise the directors of the NIH, the National Cancer Institute, and the National Center for Complementary and Alternative Medicine. The 13-member panel assesses summaries of evidence and makes recommendations about future directions in research. It is chaired by Ernst Wynder, MD, of the American Health Foundation.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.